Previous Article | Next Article ![]()
Journal of Virology, November 2000, p. 10778-10784, Vol. 74, No. 22
Molecular Medicine and Gene Therapy,
Department of Medicine, Lund University Hospital,
Lund,1 and Department of
Microbiology, Umeå University, Umeå,2 Sweden,
and Department of Genetics and Microbiology, University of
Geneva, Geneva, Switzerland3
Received 15 May 2000/Accepted 19 August 2000
The murine embryonal stem (ES) cell virus (MESV) can express
transgenes from the long terminal repeat (LTR) promoter/enhancer in
undifferentiated ES cells, but expression is turned off upon differentiation to embryoid bodies (EBs) and hematopoietic cells in
vitro. We examined whether a human immunodeficiency virus type 1-based
lentivirus vector pseudotyped with the vesicular stomatitis virus G
protein (VSV-G) could transduce ES cells efficiently and express the
green fluorescent protein (GFP) transgene from an internal
phosphoglycerate kinase (PGK) promoter throughout development to
hematopoietic cells in vitro. An oncoretrovirus vector containing the
MESV LTR and the GFP gene was used for comparison.
Fluorescence-activated cell sorting analysis of transduced CCE ES cells
showed 99.8 and 86.7% GPF-expressing ES cells in the
VSV-G-pseudotyped lentivirus (multiplicity of infection [MOI] = 59)- and oncoretrovirus (MOI = 590)-transduced cells,
respectively. Therefore, VSV-G pseudotyping of lentiviral and
oncoretrovirus vectors leads to efficient transduction of ES
cells. Lentivirus vector integration was verified in the ES cell
colonies by Southern blot analysis. When the
transduced ES cells were differentiated in vitro, expression from the
oncoretrovirus LTR was severely reduced or extinct in day 6 EBs and ES
cell-derived hematopoietic colonies. In contrast, many
lentivirus-transduced colonies, expressing the GFP gene in the
undifferentiated state, continued to express the transgene
throughout in vitro development to EBs at day 6, and many continued to
express in cells derived from hematopoietic colonies. This experimental
system can be used to analyze lentivirus vector design for optimal
expression in hematopoietic cells and for gain-of-function experiments
during ES cell development in vitro.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Lentivirus Vector Gene Expression during ES
Cell-Derived Hematopoietic Development In Vitro


*
Corresponding author. Mailing address: Molecular
Medicine and Gene Therapy, Lund University, WNC, Sölvegatan 17, 223 62 Lund, Sweden. Phone: 46 46 222 05 77. Fax: 46 46 222 05 78. E-mail: Stefan.Karlsson{at}molmed.lu.se.
Present address: Department of Cell and Molecular Biology,
Karolinska Institute, Stockholm, Sweden.
Present address: Children's Hospital, Division of
Hematology/Oncology, Boston, Mass.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»